MedTrace Logo

Study to Evaluate the Effectiveness of Certain Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants During Pregnancy and Evaluate Newborn Outcomes

NCT00553917 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2024-04-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate if during pregnancy, a common group of antidepressant medications (SSRI's) adequately treats the symptoms of depression and to evaluate if there are any effects of these medications on the newborn infant.

Conditions

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Jamie L Renbarger, MD · Indiana University School of Medicine Department of Medicine and Pediatrics

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00553917 on ClinicalTrials.gov